1. Moore, P. K., Hsu, R. K., & Liu, K. D. (2018). Management of acute kidney injury: core curriculum. American Journal of Kidney Diseases, 13, 14–15.
2. Bellomo, R., Kellum, J. A., & Ronco, C. (2012). Acute kidney injury. The Lancet, 380(9843), 756–766.
3. Večerić-Haler, Ž., Cerar, A., and Perše, M. (2017). (Mesenchymal) stem cell-based therapy in cisplatin-induced acute kidney injury animal model: risk of immunogenicity and tumorigenicity. Stem Cells International, 2017.
4. Morigi, M., & Benigni, A. (2013). Mesenchymal stem cells and kidney repair. Nephrology, Dialysis, Transplantation, 28(4), 788–793.
5. Morigi, M., Rota, C., Montemurro, T., Cicero, V. L., Imberti, B., Abbate, M., Zoia, C., Cassis, P., Longaretti, L., Rebulla, P., Introna, M., Capelli, C., Benigni, A., Remuzzi, G., & Lazzari, L. (2010). Life-sparing effect of human cord blood-mesenchymal stem cells in experimental acute kidney injury. Stem Cells, 28, 513–522.